{
  "nct_id": "NCT19395346",
  "indication": "Hypertension",
  "phase": "Phase 2/3",
  "sample_size": 718,
  "duration_weeks": 55,
  "dropout_rate": 0.23,
  "blinding": "double-blind",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "DBP reduction"
  ],
  "secondary_endpoints": [
    "24-hour ambulatory BP reduction"
  ],
  "outcome_summary": "No significant difference compared to placebo",
  "success": 0,
  "failure_reason": "Target population too heterogeneous",
  "start_date": "2020-12-02",
  "completion_date": "2021-12-22"
}